XML 41 R29.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2022
Fair Value Disclosures [Abstract]  
Schedule of Fair Value of Assets and Liabilities Measured on a Recurring Basis
The following tables summarize the Company’s financial assets and liabilities that are measured at fair value on a recurring basis:
  Fair Value Measurements
 December 31,
2021
 Quoted Prices in Active Markets for Identical Assets (Level 1)Significant Other Observable Inputs (Level 2)Significant Unobservable Inputs (Level 3)
Financial Assets    
Investments in marketable securities$78.5 $64.5 $14.0 $— 
Derivative financial instruments(1)
0.9 — 0.9 — 
Financial Liabilities(2)
    
Contingent payment obligations$40.3 $— $— $40.3 
Affiliate equity purchase obligations12.6 — — 12.6 
Derivative financial instruments0.8 — 0.8 — 
  Fair Value Measurements
 March 31,
2022
 Quoted Prices in Active Markets for Identical Assets (Level 1)Significant Other Observable Inputs (Level 2)Significant Unobservable Inputs (Level 3)
Financial Assets    
Investments in marketable securities$81.1 $68.2 $12.9 $— 
Derivative financial instruments(1)
1.0 — 1.0 — 
Financial Liabilities(2)
    
Contingent payment obligations$31.4 $— $— $31.4 
Affiliate equity purchase obligations47.6 — — 47.6 
Derivative financial instruments0.9 — 0.9 — 
__________________________
(1)Amounts are presented within Other assets on the Consolidated Balance Sheets.
(2)Amounts are presented within Other liabilities on the Consolidated Balance Sheets.
Schedule of Changes in Level 3 Assets and Liabilities for Affiliate equity repurchase obligation
The following table presents the changes in level 3 liabilities:
 For the Three Months Ended March 31,
20212022
Contingent Payment ObligationsAffiliate
Equity Purchase
Obligations
Contingent Payment ObligationsAffiliate
Equity Purchase
Obligations
Balance, beginning of period$— $22.0 $40.3 $12.6 
Net realized and unrealized (gains) losses(1)
— 0.9 (8.9)(0.3)
Purchases and issuances(2)
— 70.7 — 40.6 
Settlements and reductions— (27.5)— (5.3)
Balance, end of period$— $66.1 $31.4 $47.6 
Net change in unrealized gains relating to instruments still held at the reporting date$— $— $(8.9)$(0.3)
___________________________
(1)Gains and losses resulting from changes to expected payments are included in Other expenses (net) and the accretion of these obligations is included in Interest expense in the Consolidated Statements of Income.
(2)Affiliate equity purchase obligation activity includes transfers from Redeemable non-controlling interests.
Schedule of Quantitative Information used in Valuing Level 3 Liabilities
The following table presents certain quantitative information about the significant unobservable inputs used in valuing the Company’s level 3 fair value measurements:
 Quantitative Information About Level 3 Fair Value Measurements
December 31, 2021March 31, 2022
 Valuation
Techniques
Unobservable
Input
Fair ValueRange
Weighted Average(1)
Fair Value Range
Weighted Average(1)
Contingent payment obligationsMonte Carlo SimulationVolatility $40.3 
13% - 25%
13 %$31.4 
18% - 25%
18 %
Discount rates
1% - 2%
%
3% - 3%
%
Affiliate equity purchase obligationsDiscounted cash flow
Growth rates(2)
$12.6 
(13)% - 7%
%$47.6 
(13)% - 7%
%
 Discount rates 
15% - 18%
15 % 
15% - 18%
15 %
___________________________
(1)Calculated by comparing the relative fair value of an obligation to its respective total.
(2)Represents growth rates of asset- and performance-based fees.
Schedule of Other Financial Assets and Liabilities Not Carried at Fair Value
The following table summarizes the Company’s other financial liabilities not carried at fair value:
 December 31, 2021March 31, 2022
Carrying ValueFair ValueCarrying ValueFair ValueFair Value Hierarchy
Senior notes$1,098.0 $1,165.6 $1,098.1 $1,102.5 Level 2
Junior subordinated notes765.8 809.1 765.8 697.0 Level 2
Junior convertible securities299.5 461.4 386.3 407.3 Level 2